Tonix Pharmaceuticals (NASDAQ: TNXP) released selected preliminary financial results for 2024, reporting approximately $98.8 million in cash and cas ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Tonix Pharmaceuticals (TNXP) stock jumped 11% Friday after the company issued a business update along with a preliminary 2024 earnings report.

Tonix Pharmaceuticals has reported positive topline outcomes from its Phase I single ascending dose study of its ...

Tonix shares are moving higher on Friday after the company provided preliminary 2024 fiscal-year financial results.

Company had $98.8 million in cash as of December 31, 2024; existing cash expected to fund planned operations into the first quarter of 2026 Company is debt-free after repaying mortgage on facilities ...

Company had $98.8 million in cash as of December 31, 2024; existing cash expected to fund planned operations into the first ...

Minds + Assembly, a 2024 MM+M Agency 100 honoree, added Chuck Hemann as chief integration officer and Jonathan Woodring as ...

Tonix Pharmaceuticals saw its shares swing wildly between gains and losses on Wednesday morning as they started to trade ...

The stock markets in the US opened higher on February 4 as investors remained cautious about China’s stance on the Trump ...